Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients
13 May 2015 | By Victoria White
A Phase I clinical trial of INVAC-1, an innovative therapeutic DNA vaccine, which specifically targets the telomerase enzyme (hTERT), has commenced...